9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Impact of an Automatically Generated Cancer Survivorship Care Plan on Patient-Reported Outcomes in Routine Clinical Practice: Longitudinal Outcomes of a Pragmatic, Cluster Randomized Trial.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study was conducted to longitudinally assess the impact of an automatically generated survivorship care plan (SCP) on patient-reported outcomes in routine clinical practice. Primary outcomes were patient satisfaction with information and care. Secondary outcomes included illness perceptions and health care use.

          Related collections

          Author and article information

          Journal
          J. Clin. Oncol.
          Journal of clinical oncology : official journal of the American Society of Clinical Oncology
          1527-7755
          0732-183X
          Nov 1 2015
          : 33
          : 31
          Affiliations
          [1 ] Kim A.H. Nicolaije, Nicole P.M. Ezendam, Wobbe P. Zijlstra, and Lonneke V. van de Poll-Franse, Tilburg University, Tilburg; Kim A.H. Nicolaije, Nicole P.M. Ezendam, and Lonneke V. van de Poll-Franse, Comprehensive Cancer Center the Netherlands, Eindhoven; M. Caroline Vos and Dorry Boll, Elisabeth-TweeSteden Hospital, Tilburg and Waalwijk; Erik A. Boss, Maxima Medical Center, Veldhoven and Eindhoven, the Netherlands; Ralph H.M. Hermans, Catharina Hospital, Eindhoven; Karin C.M. Engelhart, St Anna Hospital, Geldrop and Eindhoven; Joke E. Haartsen, Elkerliek Hospital, Helmond; Brenda M. Pijlman, Jeroen Bosch Hospital, 's-Hertogenbosch; Ingrid E.A.M. van Loon- Baelemans, Amphia Hospital, Breda and Oosterhout; Helena J.M.M. Mertens, Orbis Medical Center, Sittard; Willem E. Nolting, St Jans Hospital, Weert; Johannes J. van Beek, VieCuri Hospital, Venlo and Venray; Jan A. Roukema, Tilburg University and Elisabeth-TweeSteden Hospital Tilburg; and Roy F.P.M. Kruitwagen, Maastricht University Medical Center, Maastricht, the Netherlands.
          [2 ] Kim A.H. Nicolaije, Nicole P.M. Ezendam, Wobbe P. Zijlstra, and Lonneke V. van de Poll-Franse, Tilburg University, Tilburg; Kim A.H. Nicolaije, Nicole P.M. Ezendam, and Lonneke V. van de Poll-Franse, Comprehensive Cancer Center the Netherlands, Eindhoven; M. Caroline Vos and Dorry Boll, Elisabeth-TweeSteden Hospital, Tilburg and Waalwijk; Erik A. Boss, Maxima Medical Center, Veldhoven and Eindhoven, the Netherlands; Ralph H.M. Hermans, Catharina Hospital, Eindhoven; Karin C.M. Engelhart, St Anna Hospital, Geldrop and Eindhoven; Joke E. Haartsen, Elkerliek Hospital, Helmond; Brenda M. Pijlman, Jeroen Bosch Hospital, 's-Hertogenbosch; Ingrid E.A.M. van Loon- Baelemans, Amphia Hospital, Breda and Oosterhout; Helena J.M.M. Mertens, Orbis Medical Center, Sittard; Willem E. Nolting, St Jans Hospital, Weert; Johannes J. van Beek, VieCuri Hospital, Venlo and Venray; Jan A. Roukema, Tilburg University and Elisabeth-TweeSteden Hospital Tilburg; and Roy F.P.M. Kruitwagen, Maastricht University Medical Center, Maastricht, the Netherlands. l.vd.poll@uvt.nl.
          Article
          JCO.2014.60.3399
          10.1200/JCO.2014.60.3399
          26304900
          91b79ebf-d705-4f7c-a326-39979f30d95f
          © 2015 by American Society of Clinical Oncology.
          History

          Comments

          Comment on this article